INTIMATION FOR RE-CONSTITUTION OF COMMITTEES OF THE BOARD

Gayatri BioOrganics held a board meeting on 28 May 2025 where it approved audited standalone results for Q4 and FY25. Two Independent Directors — Mr. Murali Vittala and Mr. Ramachandra Seshaprasad Chodavarpu — resigned citing advancing age. To fill the gap, the company appointed Mr. Srinivas Iduri as a new Independent Director for 5 years and re-designated Ms. Meenakshi Ramchand Sachdeva from non-executive non-independent to Independent Director for 5 years (subject to shareholder approval). Audit and Nomination & Remuneration Committees were reconstituted with Mr. P. V. Narayana Rao as chairperson. The board also appointed M/s. Vas & Co. as Internal Auditors for FY26 and M/s. Vivek Surana & Associates as Secretarial Auditors for a 5-year term (FY26–FY30). FY25 revenue stood at ₹16.22 lakh vs ₹8.50 lakh in FY24, but the company reported a wider loss before tax of ₹72.65 lakh (FY24 loss: ₹68.12 lakh), with deeply negative other equity of ₹(11,468) lakh and a going-concern comfort letter from promoters.